If you entered a web address please check it was correct.
\nYou can also try Search Page to find the study you are looking for.
"}}},"trialDetailsJson":{"title":"Details Page","returnSearch":"Back to search results","description":"Study Description","identifier":"ViiV Study ID","clinicalID":"Clinicaltrials.gov Identifier","EudraCtID":"EudraCT Number","resultsAvailable":"Has Results Available Below","docAvailable":"Has Results Document Available","studyOverview":"Study Overview","overviewSection":{"conditionsDisplay":"Medical Conditions","product":"Product","collaborators":"Collaborators","dates":"Date","studyType":"Type","phase":"Phase","gender":"Gender","age":"Age","acceptVolunteers":"Accepts Healthy Volunteers"},"studyDocuments":"Study Documents","noDocuments":"No documents available","studyDocumentsAdditionalText":"If you wish to request for Full Study Report, please contact - ","studyDocumentsAdditionalEmail":"GSKClinicalSupportHD@gsk.com","isReleased":{"firstPart":"This study has Protocol and Result summary on ClinicalTrial.gov. Click","secondPart":"to learn more.","linkText":"here"},"mapLocations":"Locations","centralContact":"Central Contact","centralPhone":"Central Contact Phone","centralEmail":"Central Contact Email","mapSection":{"site":"GSK Investigational Site","condition":"Condition","id":"Study ID","city":"City","state":"State","zip":"Zip","country":"Country"},"studyDesign":"Study Design","designSection":{"purpose":"Primary Purpose","allocation":"Allocation","study_design":"Study Design","study_classification":"Study Classification","masking":"Masking","masked_subject":"Masked Subject","masked_caregiver":"Masked Caregiver","masked_investigator":"Masked Investigator","masked_assessor":"Masked Assessor","primary_outcomes":"Primary Outcomes","secondary_outcomes":"Secondary Outcomes","arms":"Arms","interventions":"Interventions","keyword":"Keyword","inclusionTitle":"Inclusion Criteria","exclusionTitle":"Exclusion Criteria","criteriaText":"Inclusion/Exclusion Criteria","criteria_button":"Click to view inclusion/exclusion criteria","enrollment":"Enrollment","clinicalPublications":"Clinical Publications"},"popoversText":{"studyId":{"childMarkdownRemark":{"html":"A unique number for a study given by ViiV.
"}},"ctGov":{"childMarkdownRemark":{"html":"This number identifies the study on the US clinicaltrials.gov register. Click this link to go to the entry for this study on Clinicaltrials.gov where you will be able to see protocol and results summaries where available.
"}},"eudraCT":{"childMarkdownRemark":{"html":"This number identifies the study on the EU clinicaltrials.eu register. Click this link to go to the entry for this study on clinicaltrials.eu where you will be able to see protocol and results summaries where available.
"}}}},"site":{"siteMetadata":{"siteUrl":"https://www.viiv-studyregister.com"}},"studyDetails":{"nct_number":"","ctis_id":"","HasResults":"false","IpdAccessCriteria":"","IpdDescription":"","IpdInfoTypeAnalyticCode":"false","IpdInfoTypeIcf":"false","IpdInfoTypeCsr":"false","IpdInfoTypeProtocol":"false","IpdInfoTypeSap":"false","IpdTimeFrame":"","IpdUrl":"","IsFlexibleTrial":false,"IsReleasedToCtGov":"false","MaskingInfo":{"masked_assessor":"","masked_caregiver":"","masked_investigator":"","masked_subject":"","masking_description":"","no_masking":""},"PatientLevelData":"false","SharingIpd":"No","acronym":"","allocation":"","arm_groups":[{"arm_group_label":"Participants with renal anemia","arm_group_description":"Data will be collected from participants, who receive Duvroq for the first time to treat renal anemia.","arm_type":""}],"assignment":"","brief_summary":"The study aims to confirm the safety of Duvroq tablets in daily clinical practice for the treatment of renal anemia. This study will include participants, who receive Duvroq for the first time in order to treat renal anemia. The observation period per participant will be for 52 weeks from the start date of Duvroq administration and the total duration of the study will be 2 years. Approximately 1500 participants will be enrolled in this study.","brief_summary_OneLinkTx":"","brief_title_OneLinkTx":"","brief_title":"An observational study to confirm the safety of Duvroq in daily clinical practice","conditions":[{"DisplayValue":"Anemia","DisplayValue_OneLinkTx":"","InternalValue":"CON_ANEMIA","LookupValue":"anemia","LookupValue_OneLinkTx":""}],"created_date":"04/06/2026 14:20:24","criteria":"Inclusion Criteria:\n - Participants receiving Duvroq for the first time in order to treat renal anemia.\n - An informed consent should be obtained from the participants or participant’s representative.\n\nExclusion Criteria:\n - Not applicable.","detailed_description":"","display_gender":"Both","display_gender_internal":"GENDER_ALL","display_phase":"N/A","display_phase_internal":"PHASE_NA","display_status":"Ongoing","display_status_internal":"RECSTATUS_O_ONGOING","endpoint":"","enrollment":"1500","exclusion":"","gender":"All","gender_based":"No","gender_description":"","healthy_volunteers":"No","id":"d7084fb1-05ae-5cfc-9021-b86ed95e2061","internal":{"content":null,"contentDigest":"e117b15390b5ac495ae384f672e96d59","description":null,"fieldOwners":null,"mediaType":null,"ignoreType":null,"owner":"default-site-plugin","type":"studyDetails"},"inclusion":"Inclusion Criteria:\n - Participants receiving Duvroq for the first time in order to treat renal anemia.\n - An informed consent should be obtained from the participants or participant’s representative.\n\nExclusion Criteria:\n - Not applicable.","interventions":[],"interventional_subtype":"Treatment","is_fda_regulated":false,"is_high_value":false,"is_ind_study":false,"keywords":["Duvroq","daprodustat","Safety","Renal Anemia"],"last_follow_up_date":"07/15/2022 00:00:00","links":[],"locations":[{"City":"Tokyo","Latitude":"35.6710403","CountryDisplay":"Japan","Longitude":"139.7345469","Name":"GSK Investigational Site","StateDisplay":null,"PostalCode":"107-0052","StatusDisplay":"Active, not recruiting","StatusDisplayInternal":"LOCSTATUS_ACTIVE_NOT_REC","StatusMapped":"Recruitment Complete"}],"masking":"","maximum_age_raw":"N/A","maximum_age":"N/A","minimum_age":"N/A","minimum_age_raw":"N/A","modified_date":"04/06/2026 14:20:24","number_of_arms":"","observational_design":{"biospecimen_description":"","biospecimen_retention":"None Retained","number_of_groups":"1","observational_study_design":"Cohort","patient_registry":"false","target_duration_quantity":"","target_duration_units":"","timing":"Prospective"},"official_title":"DUVROQ Tablet General Drug Use Investigation (Renal Anaemia)","org_study_id":"ViiV214119","overall_contact":{"email":"GSKClinicalSupportHD@gsk.com","last_name":"Call Center","phone":"877-379-3718"},"overall_status":"Active, not recruiting - Observational","oversight_info":{"exported_from_us":"","fda_regulated_device":"No","fda_regulated_drug":"No","ped_postmarket_surv":"","has_dmc":false,"post_prior_to_approval":"","regulatory_authorities":[""]},"phase":"N/A","primary_compl_date":"07/15/2022 00:00:00","primary_outcomes":[{"outcome_description":"Proportion of patients with AEs including safety specifications will be analyzed.","outcome_measure":"Percentage of participants with adverse events (AEs)","outcome_time_frame":"Up to Week 52","outcome_safety_issue":null},{"outcome_description":"Number, type and degree of ADRs will be collected.","outcome_measure":"Occurrences of adverse drug reactions (ADRs)","outcome_time_frame":"Up to Week 52","outcome_safety_issue":null},{"outcome_description":"Participants with malignant tumor will be analyzed.","outcome_measure":"Occurrences of malignant tumor","outcome_time_frame":"Up to 2 years","outcome_safety_issue":null}],"product_name":"","product_name_OneLinkTx":"","secondary_ids":[],"secondary_outcomes":[{"outcome_description":"","outcome_measure":"","outcome_time_frame":"","outcome_safety_issue":null}],"sponsors":{"investigator_affiliation":"","investigator_username":"","lead_sponsor":"ViiV Healthcare","collaborators":[]},"start_date":"11/10/2020 00:00:00","study_type":"Observational","therapeutic_area":"","citations":[],"is_section_801":null}},"pageContext":{"studyId":"ViiV214119"}},"staticQueryHashes":["162689979","3332233851","3729204765","3769354840","399703114"]}